DC Circ. Spends Hours Debating 'Same' Generic Label Reqs
The D.C. Circuit spent more than three hours Thursday going round with Vanda Pharmaceuticals and the U.S. Food and Drug Administration about whether the label for a generic sleep-wake disorder medication...To view the full article, register now.
Already a subscriber? Click here to view full article